TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,200 | -22.7% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $28,723 | +1.2% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $28,388 | -5.1% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29,898 | -6.6% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | -13.5% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $37,000 | +15.6% | 30,200 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $32,000 | -25.6% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $43,000 | -33.8% | 30,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $65,000 | -26.1% | 30,200 | +0.7% | 0.01% | -25.0% |
| Q2 2021 | $88,000 | -22.1% | 30,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $113,000 | -0.9% | 30,000 | 0.0% | 0.01% | -15.4% |
| Q4 2020 | $114,000 | +103.6% | 30,000 | +7.5% | 0.01% | +85.7% |
| Q3 2020 | $56,000 | +27.3% | 27,900 | +39.5% | 0.01% | +16.7% |
| Q2 2020 | $44,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |